Show simple item record

dc.contributor.authorSeenath, M M
dc.contributor.authorRoberts, Darren L
dc.contributor.authorCawthorne, Christopher
dc.contributor.authorSaunders, Mark P
dc.contributor.authorArmstrong, G
dc.contributor.authorO'Dwyer, Sarah T
dc.contributor.authorStratford, Ian J
dc.contributor.authorDive, Caroline
dc.contributor.authorRenehan, Andrew G
dc.date.accessioned2009-05-13T16:11:05Z
dc.date.available2009-05-13T16:11:05Z
dc.date.issued2008-08-05
dc.identifier.citationReciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein bid in ex vivo colorectal cancer. 2008, 99 (3):459-63 Br. J. Canceren
dc.identifier.issn1532-1827
dc.identifier.pmid18648372
dc.identifier.doi10.1038/sj.bjc.6604474
dc.identifier.urihttp://hdl.handle.net/10541/68040
dc.description.abstractHypoxia inducible factor 1 (HIF-1) represses the transcription of pro-apoptotic bid in colorectal cancer cells in vitro. To assess the clinical relevance of this observation, HIF-1alpha and Bid were assessed in serial sections of 39 human colorectal adenocarcinomas by immunohistochemistry. In high HIF-1alpha nuclear-positive cell subpopulations, there was a significant reduction in Bid expression (ANOVA, P=0.04). Given the role of Bid in drug-induced apoptosis, these data add impetus to strategies targeting HIF-1 for therapeutic gain.
dc.language.isoenen
dc.subjectColorectal Canceren
dc.subjectTumour Hypoxiaen
dc.subject.meshAdenocarcinoma
dc.subject.meshAnalysis of Variance
dc.subject.meshApoptosis
dc.subject.meshBH3 Interacting Domain Death Agonist Protein
dc.subject.meshColorectal Neoplasms
dc.subject.meshHumans
dc.subject.meshHypoxia-Inducible Factor 1, alpha Subunit
dc.subject.meshImmunohistochemistry
dc.titleReciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein bid in ex vivo colorectal cancer.en
dc.typeArticleen
dc.contributor.departmentClinical and Experimental Pharmacology, Paterson Institute of Cancer Research, Manchester, UK.en
dc.identifier.journalBritish Journal of Canceren
html.description.abstractHypoxia inducible factor 1 (HIF-1) represses the transcription of pro-apoptotic bid in colorectal cancer cells in vitro. To assess the clinical relevance of this observation, HIF-1alpha and Bid were assessed in serial sections of 39 human colorectal adenocarcinomas by immunohistochemistry. In high HIF-1alpha nuclear-positive cell subpopulations, there was a significant reduction in Bid expression (ANOVA, P=0.04). Given the role of Bid in drug-induced apoptosis, these data add impetus to strategies targeting HIF-1 for therapeutic gain.


This item appears in the following Collection(s)

Show simple item record